Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.75 USD | +2.34% | -17.30% | +495.24% |
Business Summary
Number of employees: 42
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paul-Peter Tak
CEO | Chief Executive Officer | 64 | 20-08-31 |
Founder | 66 | 01-12-31 | |
Charles Schoch
DFI | Director of Finance/CFO | 39 | - |
Seshu Tyagarajan
CTO | Chief Tech/Sci/R&D Officer | 57 | 22-03-01 |
Francesca Barone
CTO | Chief Tech/Sci/R&D Officer | 47 | 20-10-31 |
William Nichols
CTO | Chief Tech/Sci/R&D Officer | 55 | 22-09-11 |
Ileen B. Winick
HRO | Human Resources Officer | - | 20-12-31 |
Nathan Caffo
PRN | Corporate Officer/Principal | 55 | 20-08-31 |
Susan Stewart
LAW | General Counsel | 64 | 20-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Papa
BRD | Director/Board Member | 68 | 22-08-07 |
Edward Benz
BRD | Director/Board Member | 78 | 17-08-31 |
Paul Manning
CHM | Chairman | 68 | 18-10-31 |
Gary Nabel
BRD | Director/Board Member | 70 | 22-08-07 |
Founder | 66 | 01-12-31 | |
Paul-Peter Tak
CEO | Chief Executive Officer | 64 | 20-08-31 |
Renee Gaeta
BRD | Director/Board Member | 42 | 22-08-07 |
Diem Nguyen
BRD | Director/Board Member | 52 | 21-07-14 |
Director/Board Member | 45 | 18-10-31 | |
Nicoletta Loggia
BRD | Director/Board Member | - | 23-06-06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,867,339 | 20,005,186 ( 66.98 %) | 122,608 ( 0.4105 %) | 66.98 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+495.24% | 261M | |
+48.67% | 56.69B | |
-2.76% | 41B | |
+37.23% | 38.11B | |
-11.22% | 26.89B | |
+9.25% | 25.59B | |
-23.10% | 18.59B | |
+1.88% | 12.39B | |
+26.43% | 11.99B | |
+21.74% | 11.88B |
- Stock Market
- Equities
- CADL Stock
- Company Candel Therapeutics, Inc.